Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ZimVie Inc. - Common Stock
(NQ:
ZIMV
)
18.15
+3.36 (+22.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ZimVie Inc. - Common Stock
< Previous
1
2
3
4
Next >
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
November 01, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
October 31, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
October 24, 2023
From
ZimVie Inc.
Via
GlobeNewswire
Barclays Maintains Underweight Rating for ZimVie: Here's What You Need To Know
August 08, 2023
Via
Benzinga
ZimVie (ZIMV) Q2 2023 Earnings Call Transcript
August 02, 2023
ZIMV earnings call for the period ending June 30, 2023.
Via
The Motley Fool
ZimVie's Earnings Outlook
August 01, 2023
Via
Benzinga
ZimVie's Return On Capital Employed Insights
May 12, 2023
Via
Benzinga
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
ZimVie (ZIMV) Q1 2023 Earnings Call Transcript
May 04, 2023
ZIMV earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles
October 18, 2023
Although few really enjoy talking about the subject, targeting stocks to sell is just as important for success as acquiring good ideas.
Via
InvestorPlace
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
October 17, 2023
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
October 11, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
October 10, 2023
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
September 26, 2023
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
August 17, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
August 10, 2023
Smaller height implants in all Mobi-C footprints to address patient anatomy
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
August 02, 2023
From
ZimVie Inc.
Via
GlobeNewswire
Earnings Scheduled For August 2, 2023
August 02, 2023
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
Via
Benzinga
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
July 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
May 22, 2023
From
ZimVie Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
May 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 04, 2023
Via
Benzinga
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
May 03, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
April 27, 2023
Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental...
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
April 13, 2023
New offerings in ZimVie’s extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
April 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
April 03, 2023
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
March 23, 2023
Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to...
From
ZimVie Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.